These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1581240)

  • 21. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
    Fjornes T; Wiedemann GJ; Sack K; Jelkmann W
    Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.
    Beguin Y; Oris R; Fillet G
    Bone Marrow Transplant; 1993 Apr; 11(4):285-92. PubMed ID: 8485476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of anemia in W/WV mice by recombinant human erythropoietin (rHuEPO) mediated through EPO receptors with lowered affinity.
    Kabaya K; Akiyama H; Nishi N; Misaizu T; Okada Y; Kawagishi M; Amano K; Kusaka M; Seki M; Uzumaki H
    Life Sci; 1995; 57(11):1067-76. PubMed ID: 7658914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs.
    Mitus AJ; Antin JH; Rutherford CJ; McGarigle CJ; Goldberg MA
    Blood; 1994 Apr; 83(7):1952-7. PubMed ID: 8142661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P
    Eur J Cancer; 2004 Oct; 40(15):2201-16. PubMed ID: 15454245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The secretory erythropoietin response in patients with multiple myeloma and Waldenström's macroglobulinaemia.
    Nielsen OJ; Brandt M; Drivsholm A
    Scand J Clin Lab Invest; 1990 Nov; 50(7):697-703. PubMed ID: 2127316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of recombinant human erythropoietin on haemolytic anaemia in mice.
    Cynshi O; Shimonaka Y; Higuchi M; Imai N; Suzuki H; Togashi M; Okamoto MT; Hirashima K
    Br J Haematol; 1990 Nov; 76(3):414-9. PubMed ID: 2261351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of recombinant human erythropoietin on anticancer drug-induced anaemia.
    Matsumoto T; Endoh K; Kamisango K; Akamatsu K; Koizumi K; Higuchi M; Imai N; Mitsui H; Kawaguchi T
    Br J Haematol; 1990 Aug; 75(4):463-8. PubMed ID: 2206997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
    Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
    Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia.
    Schrezenmeier H; Noé G; Raghavachar A; Rich IN; Heimpel H; Kubanek B
    Br J Haematol; 1994 Oct; 88(2):286-94. PubMed ID: 7803272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
    Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
    Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating erythropoietin in patients with acquired aplastic anaemia.
    Kojima S; Matsuyama T; Kodera Y
    Acta Haematol; 1995; 94(3):117-22. PubMed ID: 7502626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with recombinant human erythropoietin in children with malignancies.
    Bolonaki I; Stiakaki E; Lydaki E; Dimitriou H; Kambourakis A; Kalmantis T; Kalmanti M
    Pediatr Hematol Oncol; 1996; 13(2):111-21. PubMed ID: 8721025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Successful treatment of prolonged anemia after major ABO incompatible bone marrow transplantation for a case of myelodysplastic syndrome with recombinant erythropoietin].
    Koda K; Hayashi S; Ikeda K; Morita K; Tsuji Y; Takimoto R; Fujisaki Y; Nakazawa O
    Rinsho Ketsueki; 1992 Jul; 33(7):991-3. PubMed ID: 1507422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications.
    Markham A; Bryson HM
    Drugs; 1995 Feb; 49(2):232-54. PubMed ID: 7729331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients.
    Ireland RM; Atkinson K; Concannon A; Dodds A; Downs K; Biggs JC
    Br J Haematol; 1990 Sep; 76(1):128-34. PubMed ID: 2223632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
    Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin and erythropoiesis in renal transplantation.
    Kessler M
    Nephrol Dial Transplant; 1995; 10 Suppl 6():114-6. PubMed ID: 8524479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of human recombinant erythropoietin in oncologic surgery].
    Mercuriali F
    Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin and the anemia of cancer.
    Beguin Y
    Acta Clin Belg; 1996; 51(1):36-52. PubMed ID: 8669161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.